Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization.
Xi-Yuan YangJiang-Bei DengTian-Zhi AnShi ZhouJun-Xiang LiPublished in: The Journal of international medical research (2021)
A high OTER is a risk factor for poor OS in patients undergoing TACE. This should be taken into consideration before the procedure.